{"entity":{"type":"insider","cik":"0001397906","url":"/insider/0001397906","json_url":"/insider/0001397906.json","name":"Cha Albert","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":14,"first":"2008-02-14","last":"2023-09-13","span_basis":"filed_date"},"name_variants":[{"name":"Cha Albert","source":"filing","n_filings":7,"first_seen":"2017-05-09","last_seen":"2023-09-13"},{"name":"CHA ALBERT","source":"filing","n_filings":7,"first_seen":"2008-02-14","last_seen":"2015-10-13"}],"transactions":[{"id":8044136,"accession":"0001209191-23-049268","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-049268","line_url":"/filing/0001209191-23-049268#line-3","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001397906","owner_name":"Cha Albert","owner_display_name":"Cha Albert","owner_url":"/insider/0001397906","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":10.5028,"price_display":"10.50","price_state":"stated","total_value":189050.4,"total_display":"189,050.40","total_whole":"189,050","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-11","filed_date":"2023-09-13","scope":"insider"},{"id":2912923,"accession":"0001209191-20-056790","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-056790","line_url":"/filing/0001209191-20-056790","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001397906","owner_name":"Cha Albert","owner_display_name":"Cha Albert","owner_url":"/insider/0001397906","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":115686.0,"shares_display":"115,686","price_per_share":17.236897622875716,"price_display":"17.24","price_state":"stated","total_value":1994067.7384,"total_display":"1,994,067.74","total_whole":"1,994,068","shares_owned_after":1090748.0,"shares_owned_after_display":"1,090,748","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-30","filed_date":"2020-11-03","scope":"insider","n_lines":2},{"id":8191903,"accession":"0001567619-19-015484","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-19-015484","line_url":"/filing/0001567619-19-015484","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001397906","owner_name":"Cha Albert","owner_display_name":"Cha Albert","owner_url":"/insider/0001397906","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29867.0,"shares_display":"29,867","price_per_share":17.1327,"price_display":"17.13","price_state":"stated","total_value":511702.3509,"total_display":"511,702.35","total_whole":"511,702","shares_owned_after":1022493.0,"shares_owned_after_display":"1,022,493","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-29","filed_date":"2019-07-30","scope":"insider","n_lines":2},{"id":8191891,"accession":"0001567619-19-015484","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-015484","line_url":"/filing/0001567619-19-015484","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001397906","owner_name":"Cha Albert","owner_display_name":"Cha Albert","owner_url":"/insider/0001397906","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26500.0,"shares_display":"26,500","price_per_share":16.8315,"price_display":"16.83","price_state":"stated","total_value":446034.75,"total_display":"446,034.75","total_whole":"446,035","shares_owned_after":997763.0,"shares_owned_after_display":"997,763","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-26","filed_date":"2019-07-30","scope":"insider","n_lines":2},{"id":8631424,"accession":"0001567619-19-015022","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-19-015022","line_url":"/filing/0001567619-19-015022","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001397906","owner_name":"Cha Albert","owner_display_name":"Cha Albert","owner_url":"/insider/0001397906","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":17.8096788,"price_display":"17.81","price_state":"stated","total_value":1068580.728,"total_display":"1,068,580.73","total_whole":"1,068,581","shares_owned_after":975821.0,"shares_owned_after_display":"975,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-19","filed_date":"2019-07-19","scope":"insider","n_lines":2},{"id":8631418,"accession":"0001567619-19-015022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-015022","line_url":"/filing/0001567619-19-015022","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001397906","owner_name":"Cha Albert","owner_display_name":"Cha Albert","owner_url":"/insider/0001397906","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1280.0,"shares_display":"1,280","price_per_share":16.9648140625,"price_display":"16.96","price_state":"stated","total_value":21714.962,"total_display":"21,714.96","total_whole":"21,715","shares_owned_after":926141.0,"shares_owned_after_display":"926,141","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-17","filed_date":"2019-07-19","scope":"insider","n_lines":2},{"id":6798021,"accession":"0001567619-18-002463","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-002463","line_url":"/filing/0001567619-18-002463#line-1","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"KalVista Pharmaceuticals, Inc.","issuer_ticker":"KALV","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001397906","owner_name":"Cha Albert","owner_display_name":"Cha Albert","owner_url":"/insider/0001397906","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1058824.0,"shares_display":"1,058,824","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":18000008.0,"total_display":"18,000,008.00","total_whole":"18,000,008","shares_owned_after":1359149.0,"shares_owned_after_display":"1,359,149","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-10","filed_date":"2018-09-12","scope":"insider"},{"id":6895536,"accession":"0001209191-18-005827","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-005827","line_url":"/filing/0001209191-18-005827","is_derivative":false,"issuer_cik":"0001397906","issuer_name":"Menlo Therapeutics, Inc.","issuer_ticker":"MNLO","issuer_name_source":null,"issuer_url":"/issuer/0001397906","owner_cik":"0001397906","owner_name":"Cha Albert","owner_display_name":"Cha Albert","owner_url":"/insider/0001397906","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":294118.0,"shares_display":"294,118","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":5000006.0,"total_display":"5,000,006.00","total_whole":"5,000,006","shares_owned_after":258432.0,"shares_owned_after_display":"258,432","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-25","filed_date":"2018-01-29","scope":"insider","n_lines":2},{"id":4782589,"accession":"0001209191-17-030977","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-030977","line_url":"/filing/0001209191-17-030977#line-2","is_derivative":false,"issuer_cik":"0001397906","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001397906","owner_cik":"0001397906","owner_name":"Cha Albert","owner_display_name":"Cha Albert","owner_url":"/insider/0001397906","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":470000.0,"shares_display":"470,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":7990000.0,"total_display":"7,990,000.00","total_whole":"7,990,000","shares_owned_after":1976818.0,"shares_owned_after_display":"1,976,818","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-09","filed_date":"2017-05-09","scope":"insider"},{"id":8849094,"accession":"0001209191-15-075199","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-075199","line_url":"/filing/0001209191-15-075199#line-2","is_derivative":false,"issuer_cik":"0001397906","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001397906","owner_cik":"0001397906","owner_name":"CHA ALBERT","owner_display_name":"CHA ALBERT","owner_url":"/insider/0001397906","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":454545.0,"shares_display":"454,545","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":4999995.0,"total_display":"4,999,995.00","total_whole":"4,999,995","shares_owned_after":4191397.0,"shares_owned_after_display":"4,191,397","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-10-13","filed_date":"2015-10-13","scope":"insider"},{"id":8904734,"accession":"0001209191-15-075019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-075019","line_url":"/filing/0001209191-15-075019#line-1","is_derivative":false,"issuer_cik":"0001397906","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001397906","owner_cik":"0001397906","owner_name":"CHA ALBERT","owner_display_name":"CHA ALBERT","owner_url":"/insider/0001397906","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13352.0,"shares_display":"13,352","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":146872.0,"total_display":"146,872.00","total_whole":"146,872","shares_owned_after":303206.0,"shares_owned_after_display":"303,206","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-10-07","filed_date":"2015-10-09","scope":"insider"},{"id":8300788,"accession":"0001209191-15-061933","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-061933","line_url":"/filing/0001209191-15-061933","is_derivative":false,"issuer_cik":"0001290149","issuer_name":"ProNAi Therapeutics Inc","issuer_ticker":"DNAI","issuer_name_source":null,"issuer_url":"/issuer/0001290149","owner_cik":"0001397906","owner_name":"CHA ALBERT","owner_display_name":"CHA ALBERT","owner_url":"/insider/0001397906","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":220000.0,"shares_display":"220,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":3740000.0,"total_display":"3,740,000.00","total_whole":"3,740,000","shares_owned_after":2433577.0,"shares_owned_after_display":"2,433,577","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-07-21","filed_date":"2015-07-21","scope":"insider","n_lines":2},{"id":9269595,"accession":"0001209191-15-036341","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-036341","line_url":"/filing/0001209191-15-036341","is_derivative":false,"issuer_cik":"0001397906","issuer_name":"Carbylan Therapeutics, Inc.","issuer_ticker":"CBYL","issuer_name_source":null,"issuer_url":"/issuer/0001397906","owner_cik":"0001397906","owner_name":"CHA ALBERT","owner_display_name":"CHA ALBERT","owner_url":"/insider/0001397906","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1012500.0,"shares_display":"1,012,500","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":5062500.0,"total_display":"5,062,500.00","total_whole":"5,062,500","shares_owned_after":4204562.0,"shares_owned_after_display":"4,204,562","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-04-14","filed_date":"2015-04-27","scope":"insider","n_lines":2},{"id":8372464,"accession":"0001209191-15-034050","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-15-034050","line_url":"/filing/0001209191-15-034050","is_derivative":false,"issuer_cik":"0001348911","issuer_name":"Carbylan Therapeutics, Inc.","issuer_ticker":"CBYL","issuer_name_source":null,"issuer_url":"/issuer/0001348911","owner_cik":"0001397906","owner_name":"CHA ALBERT","owner_display_name":"CHA ALBERT","owner_url":"/insider/0001397906","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1012500.0,"shares_display":"1,012,500","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":5062500.0,"total_display":"5,062,500.00","total_whole":"5,062,500","shares_owned_after":4197200.0,"shares_owned_after_display":"4,197,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-04-14","filed_date":"2015-04-14","scope":"insider","n_lines":2},{"id":6272491,"accession":"0001209191-14-070497","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001209191-14-070497","line_url":"/filing/0001209191-14-070497#line-25","is_derivative":false,"issuer_cik":"0001227162","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227162","owner_cik":null,"owner_name":"CHA ALBERT; ENGLEMAN EDGAR; Vivo Ventures Fund V, L.P.","owner_display_name":"CHA ALBERT","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1936843.0,"shares_display":"1,936,843","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2494520.0,"shares_owned_after_display":"2,494,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6272489,"accession":"0001209191-14-070497","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001209191-14-070497","line_url":"/filing/0001209191-14-070497#line-24","is_derivative":false,"issuer_cik":"0001227162","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227162","owner_cik":null,"owner_name":"CHA ALBERT; ENGLEMAN EDGAR; Vivo Ventures Fund V, L.P.","owner_display_name":"CHA ALBERT","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":585437.0,"shares_display":"585,437","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":3490418.0,"shares_owned_after_display":"3,490,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6272487,"accession":"0001209191-14-070497","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001209191-14-070497","line_url":"/filing/0001209191-14-070497#line-23","is_derivative":false,"issuer_cik":"0001227162","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227162","owner_cik":null,"owner_name":"CHA ALBERT; ENGLEMAN EDGAR; Vivo Ventures Fund V, L.P.","owner_display_name":"CHA ALBERT","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":348800.0,"shares_display":"348,800","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2900888.0,"shares_owned_after_display":"2,900,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6272485,"accession":"0001209191-14-070497","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001209191-14-070497","line_url":"/filing/0001209191-14-070497#line-22","is_derivative":false,"issuer_cik":"0001227162","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227162","owner_cik":null,"owner_name":"CHA ALBERT; ENGLEMAN EDGAR; Vivo Ventures Fund V, L.P.","owner_display_name":"CHA ALBERT","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28028.0,"shares_display":"28,028","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2545277.0,"shares_owned_after_display":"2,545,277","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6272483,"accession":"0001209191-14-070497","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001209191-14-070497","line_url":"/filing/0001209191-14-070497#line-21","is_derivative":false,"issuer_cik":"0001227162","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227162","owner_cik":null,"owner_name":"CHA ALBERT; ENGLEMAN EDGAR; Vivo Ventures Fund V, L.P.","owner_display_name":"CHA ALBERT","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22729.0,"shares_display":"22,729","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2517249.0,"shares_owned_after_display":"2,517,249","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6272481,"accession":"0001209191-14-070497","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001209191-14-070497","line_url":"/filing/0001209191-14-070497#line-20","is_derivative":false,"issuer_cik":"0001227162","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227162","owner_cik":null,"owner_name":"CHA ALBERT; ENGLEMAN EDGAR; Vivo Ventures Fund V, L.P.","owner_display_name":"CHA ALBERT","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6870.0,"shares_display":"6,870","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":3497288.0,"shares_owned_after_display":"3,497,288","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6272479,"accession":"0001209191-14-070497","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001209191-14-070497","line_url":"/filing/0001209191-14-070497#line-19","is_derivative":false,"issuer_cik":"0001227162","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227162","owner_cik":null,"owner_name":"CHA ALBERT; ENGLEMAN EDGAR; Vivo Ventures Fund V, L.P.","owner_display_name":"CHA ALBERT","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6689.0,"shares_display":"6,689","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2551966.0,"shares_owned_after_display":"2,551,966","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6272477,"accession":"0001209191-14-070497","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001209191-14-070497","line_url":"/filing/0001209191-14-070497#line-18","is_derivative":false,"issuer_cik":"0001227162","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227162","owner_cik":null,"owner_name":"CHA ALBERT; ENGLEMAN EDGAR; Vivo Ventures Fund V, L.P.","owner_display_name":"CHA ALBERT","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4093.0,"shares_display":"4,093","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2904981.0,"shares_owned_after_display":"2,904,981","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6272475,"accession":"0001209191-14-070497","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001209191-14-070497","line_url":"/filing/0001209191-14-070497#line-17","is_derivative":false,"issuer_cik":"0001227162","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227162","owner_cik":null,"owner_name":"CHA ALBERT; ENGLEMAN EDGAR; Vivo Ventures Fund V, L.P.","owner_display_name":"CHA ALBERT","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":122.0,"shares_display":"122","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2552088.0,"shares_owned_after_display":"2,552,088","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6272458,"accession":"0001209191-14-070497","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-14-070497","line_url":"/filing/0001209191-14-070497#line-7","is_derivative":false,"issuer_cik":"0001227162","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227162","owner_cik":null,"owner_name":"CHA ALBERT; ENGLEMAN EDGAR; Vivo Ventures Fund V, L.P.","owner_display_name":"CHA ALBERT","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"2014 Convertible Promissory Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1567878.63,"shares_display":"1,567,878.63","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6272455,"accession":"0001209191-14-070497","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-14-070497","line_url":"/filing/0001209191-14-070497#line-6","is_derivative":false,"issuer_cik":"0001227162","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227162","owner_cik":null,"owner_name":"CHA ALBERT; ENGLEMAN EDGAR; Vivo Ventures Fund V, L.P.","owner_display_name":"CHA ALBERT","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"2014 Convertible Promissory Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18400.64,"shares_display":"18,400.64","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6272453,"accession":"0001209191-14-070497","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-070497","line_url":"/filing/0001209191-14-070497#line-5","is_derivative":false,"issuer_cik":"0001227162","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227162","owner_cik":null,"owner_name":"CHA ALBERT; ENGLEMAN EDGAR; Vivo Ventures Fund V, L.P.","owner_display_name":"CHA ALBERT","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"2010/2012 Convertible Promissory Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9427594.51,"shares_display":"9,427,594.51","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6272451,"accession":"0001209191-14-070497","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-070497","line_url":"/filing/0001209191-14-070497#line-4","is_derivative":false,"issuer_cik":"0001227162","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227162","owner_cik":null,"owner_name":"CHA ALBERT; ENGLEMAN EDGAR; Vivo Ventures Fund V, L.P.","owner_display_name":"CHA ALBERT","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"2010/2012 Convertible Promissory Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":136440.76,"shares_display":"136,440.76","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6272449,"accession":"0001209191-14-070497","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-070497","line_url":"/filing/0001209191-14-070497#line-3","is_derivative":false,"issuer_cik":"0001227162","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227162","owner_cik":null,"owner_name":"CHA ALBERT; ENGLEMAN EDGAR; Vivo Ventures Fund V, L.P.","owner_display_name":"CHA ALBERT","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"2010/2012 Convertible Promissory Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110642.23,"shares_display":"110,642.23","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6272447,"accession":"0001209191-14-070497","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-070497","line_url":"/filing/0001209191-14-070497#line-2","is_derivative":false,"issuer_cik":"0001227162","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227162","owner_cik":null,"owner_name":"CHA ALBERT; ENGLEMAN EDGAR; Vivo Ventures Fund V, L.P.","owner_display_name":"CHA ALBERT","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"2010/2012 Convertible Promissory Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32569.17,"shares_display":"32,569.17","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6272445,"accession":"0001209191-14-070497","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-070497","line_url":"/filing/0001209191-14-070497#line-1","is_derivative":false,"issuer_cik":"0001227162","issuer_name":"Capnia, Inc.","issuer_ticker":"CAPN","issuer_name_source":null,"issuer_url":"/issuer/0001227162","owner_cik":null,"owner_name":"CHA ALBERT; ENGLEMAN EDGAR; Vivo Ventures Fund V, L.P.","owner_display_name":"CHA ALBERT","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"2010/2012 Convertible Promissory Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":595.91,"shares_display":"595.91","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":3420469,"accession":"0001209191-08-010842","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-010842","line_url":"/filing/0001209191-08-010842#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"Biodel Inc","issuer_ticker":"BIOD","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001397906","owner_name":"CHA ALBERT","owner_display_name":"CHA ALBERT","owner_url":"/insider/0001397906","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":132000.0,"shares_display":"132,000","price_per_share":15.5,"price_display":"15.50","price_state":"stated","total_value":2046000.0,"total_display":"2,046,000.00","total_whole":"2,046,000","shares_owned_after":1553632.0,"shares_owned_after_display":"1,553,632","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-02-12","filed_date":"2008-02-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":22,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001348911","name":"KalVista Pharmaceuticals, Inc.","url":"/issuer/0001348911","role":"Director","n_filings":7,"first_seen":"2015-04-14","last_seen":"2023-09-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001566044","name":"Menlo Therapeutics, Inc.","url":"/issuer/0001566044","role":"Director","n_filings":1,"first_seen":"2018-01-29","last_seen":"2018-01-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001689813","name":"Biohaven Pharmaceutical Holding Co Ltd.","url":"/issuer/0001689813","role":"Director","n_filings":1,"first_seen":"2017-05-09","last_seen":"2017-05-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001557746","name":"Aclaris Therapeutics, Inc.","url":"/issuer/0001557746","role":"Director","n_filings":2,"first_seen":"2015-10-09","last_seen":"2015-10-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001290149","name":"ProNAi Therapeutics Inc","url":"/issuer/0001290149","role":"Director","n_filings":1,"first_seen":"2015-07-21","last_seen":"2015-07-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001484565","name":"Capnia, Inc.","url":"/issuer/0001484565","role":"Ten percent owner","n_filings":1,"first_seen":"2014-11-20","last_seen":"2014-11-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001322505","name":"Biodel Inc","url":"/issuer/0001322505","role":"Director","n_filings":1,"first_seen":"2008-02-14","last_seen":"2008-02-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001397906","retrieved_at":"2026-08-22T22:53:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}